首页 | 本学科首页   官方微博 | 高级检索  
     

阿德福韦酯治疗慢性乙型肝炎65例观察
引用本文:李勇年,吴炜强,翟佩任,燕青松,那军,魏丽军,高建兴,郭晏海. 阿德福韦酯治疗慢性乙型肝炎65例观察[J]. 实用肝脏病杂志, 2011, 14(2): 110-111. DOI: 10.3969/j.issn.1672-5069.2011.02.009
作者姓名:李勇年  吴炜强  翟佩任  燕青松  那军  魏丽军  高建兴  郭晏海
作者单位:1. 解放军323医院感染病科,西安市,710054
2. 第四军医大学药学系基因研究所
摘    要:目的探讨阿德福韦酯单独或联合拉米夫定治疗慢性乙型肝炎的疗效。方法 12例HBeAg阳性患者给予阿德福韦酯,39例HBeAg阳性患者给予拉米夫定和阿德福韦酯,14例HBeAg阴性患者接受阿德福韦酯治疗。各组均观察24个月。结果联合治疗HBeAg阳性和阿德福韦酯治疗HBeAg阴性患者在治疗3个月、6个月、12个月和24个月时,血清HBV DNA水平均明显低于阿德福韦酯治疗HBeAg阳性患者;三组ALT复常率无显著性相差。结论阿德福韦酯联合拉米夫定初始治疗HBeAg阳性或阿德福韦酯治疗HBeAg阴性慢性乙型肝炎患者均能取得较好的疗效。

关 键 词:慢性乙型肝炎  阿德福韦酯  拉米夫定  治疗

Clinical study on adefovir dipivoxil treatment on patients with chronic hepatitis B:65 case report
LI Yongnian,WU Weiqiang,ZHAI Peiren,et al.. Clinical study on adefovir dipivoxil treatment on patients with chronic hepatitis B:65 case report[J]. Journal of Clinical Hepatology, 2011, 14(2): 110-111. DOI: 10.3969/j.issn.1672-5069.2011.02.009
Authors:LI Yongnian  WU Weiqiang  ZHAI Peiren  et al.
Affiliation:LI Yongnian,WU Weiqiang,ZHAI Peiren,et al.Department of Infectious Diseases,The 323rd Hospital,Xi'an 710054,P.R.China
Abstract:Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B.Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks.Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipi...
Keywords:Hepatitis B  Adefovir dipivoxil  Lamivudine  Efficacy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号